Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Chkaem1/Cya
Common Name:
Chka-KO
Product ID:
S-KO-16875
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Chka-KO
Strain ID
KOCMP-12660-Chka-B6J-VA
Gene Name
Chka
Product ID
S-KO-16875
Gene Alias
CK; CK/EK-alpha; Chetk-alpha; Chk; ChoK; EK; EtnK-alpha
Background
C57BL/6JCya
NCBI ID
12660
Modification
Conventional knockout
Chromosome
19
Phenotype
MGI:107760
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Chkaem1/Cya mice (Catalog S-KO-16875) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000072055
NCBI RefSeq
NM_013490
Target Region
Exon 3~5
Size of Effective Region
~2.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Chka, short for choline kinase α, is an enzyme that converts choline to phosphocholine. It is involved in the Kennedy pathways, which catalyze the de novo synthesis of phosphatidylcholine and phosphatidylethanolamine, crucial components of eukaryotic cell membranes [1].

Bi-allelic variants in CHKA were found in six individuals from five families, presenting with severe global developmental delay, epilepsy, movement disorders and microcephaly. Functional testing in a yeast model determined these variants reduce CHKA's enzymatic activity, impairing the first step of the Kennedy pathway, thus suggesting CHKA as a novel autosomal-recessive gene for this neurodevelopmental disorder [1].

In cancer research, CHKA is highly expressed in lung adenocarcinoma, colorectal carcinoma, and glioma tissues, closely associated with poor prognosis in lung and colorectal cancer patients [2,5,3]. Knockdown of CHKA inhibits the proliferation, invasion and migration of glioma and colorectal cancer cells [3,5]. Also, chloroquine suppresses colorectal cancer progression by targeting CHKA to inhibit the PI3K/AKT pathway [6]. In endometrial cancer, advanced glycation end products upregulate CHKA-mediated choline metabolism, activating the PI3K/AKT pathway and enhancing the cancer cells' malignant behavior [7]. Additionally, a CHKA polymorphism (rs3794186) may correlate with serum α-fetoprotein levels in hepatocellular carcinoma [8]. In a California population, a CHKA SNP (hCV1562388) was associated with a reduced risk of spina bifida [4].

In conclusion, Chka plays essential roles in the Kennedy pathway for cell-membrane lipid synthesis. Studies on Chka, especially through loss-of-function experiments in various cell models, have revealed its significance in neurodevelopmental disorders and multiple types of cancers, as well as its potential association with spina bifida and serum α-fetoprotein levels in hepatocellular carcinoma. These findings contribute to understanding the underlying mechanisms of these diseases and may provide new targets for treatment.

References:

1. Klöckner, Chiara, Fernández-Murray, J Pedro, Tavasoli, Mahtab, McMaster, Christopher R, Platzer, Konrad. . Bi-allelic variants in CHKA cause a neurodevelopmental disorder with epilepsy and microcephaly. In Brain : a journal of neurology, 145, 1916-1923. doi:10.1093/brain/awac074. https://pubmed.ncbi.nlm.nih.gov/35202461/

2. Zhang, Li, Chen, Ping, Yang, Shen, Wu, Peng, Jiang, Shujuan. 2016. CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator. In Oncology letters, 12, 1849-1853. doi:. https://pubmed.ncbi.nlm.nih.gov/27588131/

3. Yue, Fangqian, Zou, Yourui, Sun, Shengyu, Huang, Ling, Ma, Hui. . [Knockdown of choline kinase α (CHKA) inhibits the proliferation, invasion and migration of human U87MG glioma cells]. In Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 36, 724-728. doi:. https://pubmed.ncbi.nlm.nih.gov/32958130/

4. Enaw, James O Ebot, Zhu, Huiping, Yang, Wei, Lammer, Edward J, Finnell, Richard H. 2006. CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population. In BMC medicine, 4, 36. doi:. https://pubmed.ncbi.nlm.nih.gov/17184542/

5. Hu, Liang, Wang, Ruo-Yu, Cai, Jian, Zhou, Wei-Ping, Cai, Qing-Ping. . Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma. In Oncotarget, 7, 66660-66678. doi:10.18632/oncotarget.11433. https://pubmed.ncbi.nlm.nih.gov/27556502/

6. Liu, Yanqing, Zhu, Yongping, Gu, Liwei, Dai, Lingyun, Wang, Jigang. 2025. Chloroquine Suppresses Colorectal Cancer Progression via Targeting CHKA and PFKM to inhibit the PI3K/AKT Pathway and the Warburg Effect. In International journal of biological sciences, 21, 1619-1631. doi:10.7150/ijbs.101921. https://pubmed.ncbi.nlm.nih.gov/39990656/

7. Shu, Wan, Hua, Teng, Xin, Xiaoyan, Wang, Hongbo, Zhou, Xing. . Advanced glycation end products promote the progression of endometrial cancer via activating the RAGE/CHKA/PI3K/AKT signaling pathway. In Carcinogenesis, 46, . doi:10.1093/carcin/bgae059. https://pubmed.ncbi.nlm.nih.gov/39180262/

8. Park, Min-Su, Kim, Su Kang, Shin, Hyun Phil, Lee, Sang Mok, Chung, Joo-Ho. 2012. Association of CHKA polymorphism (rs3794186) with α-fetoprotein levels in hepatocellular carcinoma. In Molecular medicine reports, 6, 1371-4. doi:10.3892/mmr.2012.1081. https://pubmed.ncbi.nlm.nih.gov/22972156/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest